Long-term mortality after intracerebral hemorrhage.

Neurology
Matthew L FlahertyDaniel Woo

Abstract

To characterize long-term mortality following intracerebral hemorrhage (ICH) in two large population-based cohorts assembled more than a decade apart. All patients age > or = 18 hospitalized with nontraumatic ICH in the Greater Cincinnati/Northern Kentucky area were identified during 1988 (Cohort 1) and from May 1998 to July 2001 and August 2002 to April 2003 (Cohort 2). Mortality was tabulated using actuarial methods and compared with a log-rank test. There were 183 patients with ICH in Cohort 1 and 1,041 patients in Cohort 2. Patients in Cohort 1 were more likely to be white (p = 0.024) and undergo operation for their ICH (p = 0.002), whereas patients in Cohort 2 were more commonly on anticoagulants (p < 0.001). Among patients in Cohort 1, mortality at 7 days, 1 year, and 10 years was 31, 59, and 82%. Among patients in Cohort 2, mortality at 7 days and 1 year was 34 and 53%. Mortality rates did not differ between cohorts by log-rank test (p = 0.259). Intracerebral hemorrhage (ICH) mortality did not improve significantly between study periods. Operation for ICH became less frequent, whereas anticoagulant-associated ICH became more common.

Citations

Oct 31, 2012·JAMA Neurology·Warren D LoNicholas Zumberge
Jun 15, 2007·Advances in Therapy·Won Chan LeeMichael C Christensen
Jul 13, 2011·Journal of Neurology·Alvaro CerveraAngel Chamorro
Apr 2, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Behnam MansouriAfshin Amini
Oct 3, 2008·Neurosurgical Review·Uzma Samadani, Veit Rohde
Feb 2, 2012·International Journal of Computer Assisted Radiology and Surgery·K N Bhanu PrakashWieslaw L Nowinski
Dec 15, 2007·Vascular Health and Risk Management·Ramandeep Sahni, Jesse Weinberger
Nov 8, 2008·Current Treatment Options in Neurology·Bart M Demaerschalk, Maria I Aguilar
Sep 16, 2010·Current Treatment Options in Neurology·Maria I Aguilar, William D Freeman
Aug 19, 2011·Neurocritical Care·Lisa KnopfLouise McCullough
Jan 29, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Fazeel M SiddiquiAdnan I Qureshi
Dec 6, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·H Bart Brouwers, Joshua N Goldstein
Sep 30, 2010·Nature Reviews. Neurology·Opeolu Adeoye, Joseph P Broderick
May 16, 2008·The New England Journal of Medicine·Stanley Tuhrim
Oct 13, 2011·Journal of Neurotrauma·Yan-Hua SangRaymond Tak-Fai Cheung
Jan 21, 2012·Journal of Computer Assisted Tomography·Bhanu Prakash KNWieslaw L Nowinski
Jan 20, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C-H WuL-D Chen
Aug 18, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Y-W ChenJ-S Jeng
Jan 22, 2008·International Journal of Clinical Practice·A Bhalla, D Hargroves
Jun 6, 2012·Journal of Biomedicine & Biotechnology·Tim Lekic, Chizobam Ani
Mar 8, 2013·Cerebrovascular Diseases·H Bart Brouwers, Steven M Greenberg
Mar 17, 2009·Stroke; a Journal of Cerebral Circulation·Matthew L FlahertyDaniel Woo
Oct 8, 2011·Stroke; a Journal of Cerebral Circulation·Rajeev K GargAndrew M Naidech
May 21, 2008·BMC Neurology·Brett M Kissela, Mark H Eckman
Nov 18, 2011·Journal of Neuroinflammation·Shruti AgnihotriLouise D McCullough
May 29, 2012·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·Marco BrizziElisabet Zia
May 3, 2013·Neurosurgical Focus·Michael L KellyRobert J Weil
Oct 4, 2013·International Journal of Vascular Medicine·Gord BlackhouseRon Goeree
Jul 12, 2013·The International Journal of Neuroscience·Hong-Xing WangXiao-Ping Du
Sep 24, 2015·The International Journal of Neuroscience·Ying HuangJianqing Yuan
Oct 18, 2007·Expert Review of Neurotherapeutics·Eric Jüttler, Thorsten Steiner
Dec 18, 2013·Seminars in Roentgenology·Viesha A Ciura, Javier M Romero
Oct 24, 2012·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Candice Delcourt, Craig Anderson
Aug 21, 2012·Anesthesiology Clinics·Alana M FlexmanAdrian W Gelb

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.